⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCTX News
Briacell Therapeutics Corp. Common Shares
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
globenewswire.com
BCTX
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient
globenewswire.com
BCTX
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
prnewswire.com
ONCY
BCTX
GLSI
CTOR
KZIA
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
globenewswire.com
BCTX
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
globenewswire.com
BCTX
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
globenewswire.com
BCTX
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
globenewswire.com
BCTX
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
globenewswire.com
BCTX
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
globenewswire.com
BCTX
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
globenewswire.com
BCTX